RXMD
Price
$2.11
Change
-$0.00 (-0.00%)
Updated
Sep 27 closing price
WLCGF
Price
$16.41
Change
-$0.00 (-0.00%)
Updated
Dec 6 closing price
Ad is loading...

RXMD vs WLCGF

Header iconRXMD vs WLCGF Comparison
Open Charts RXMD vs WLCGFBanner chart's image
Progressive Care
Price$2.11
Change-$0.00 (-0.00%)
Volume$1.22K
CapitalizationN/A
Welcia Holdings
Price$16.41
Change-$0.00 (-0.00%)
Volume$120
CapitalizationN/A
RXMD vs WLCGF Comparison Chart
Loading...
View a ticker or compare two or three
VS
RXMD vs. WLCGF commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXMD is a Hold and WLCGF is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (RXMD: $2.11 vs. WLCGF: $16.41)
Brand notoriety: RXMD and WLCGF are both not notable
Both companies represent the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: RXMD: 106% vs. WLCGF: 100%
Market capitalization -- RXMD: $19.75M vs. WLCGF: $3.97B
RXMD [@Drugstore Chains] is valued at $19.75M. WLCGF’s [@Drugstore Chains] market capitalization is $3.97B. The market cap for tickers in the [@Drugstore Chains] industry ranges from $18.71B to $0. The average market capitalization across the [@Drugstore Chains] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXMD’s FA Score shows that 1 FA rating(s) are green whileWLCGF’s FA Score has 1 green FA rating(s).

  • RXMD’s FA Score: 1 green, 4 red.
  • WLCGF’s FA Score: 1 green, 4 red.
According to our system of comparison, RXMD is a better buy in the long-term than WLCGF.

Price Growth

RXMD (@Drugstore Chains) experienced а 0.00% price change this week, while WLCGF (@Drugstore Chains) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Drugstore Chains industry was +1.28%. For the same industry, the average monthly price growth was +2.67%, and the average quarterly price growth was +1.64%.

Reported Earning Dates

RXMD is expected to report earnings on Aug 15, 2023.

Industries' Descriptions

@Drugstore Chains (+1.28% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

FUNDAMENTALS
Fundamentals
WLCGF($3.97B) has a higher market cap than RXMD($19.7M). RXMD has higher P/E ratio than WLCGF: RXMD (80.00) vs WLCGF (24.51). WLCGF YTD gains are higher at: 0.000 vs. RXMD (-32.803). WLCGF has higher annual earnings (EBITDA): 43.4B vs. RXMD (-8.77M). WLCGF has more cash in the bank: 37.4B vs. RXMD (2.23M). RXMD has less debt than WLCGF: RXMD (3.01M) vs WLCGF (92.7B). WLCGF has higher revenues than RXMD: WLCGF (1.18T) vs RXMD (10.1M).
RXMDWLCGFRXMD / WLCGF
Capitalization19.7M3.97B0%
EBITDA-8.77M43.4B-0%
Gain YTD-32.8030.000-
P/E Ratio80.0024.51326%
Revenue10.1M1.18T0%
Total Cash2.23M37.4B0%
Total Debt3.01M92.7B0%
FUNDAMENTALS RATINGS
RXMD: Fundamental Ratings
RXMD
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTLSX14.760.04
+0.27%
Glenmede Quant US Long/Short Equity Ins
AVUYX8.74-0.06
-0.68%
American Century Value Y
OAIEX12.86-0.17
-1.30%
Optimum International A
FTIHX14.06-0.22
-1.54%
Fidelity Total International Index
GMSRX12.76-0.23
-1.77%
Nationwide Small Cap Index R

RXMD and

Correlation & Price change

A.I.dvisor tells us that RXMD and PETS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RXMD and PETS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXMD
1D Price
Change %
RXMD100%
N/A
PETS - RXMD
10%
Poorly correlated
-4.61%
HITI - RXMD
9%
Poorly correlated
+1.51%
WBA - RXMD
5%
Poorly correlated
-4.05%
SSY - RXMD
5%
Poorly correlated
+2.05%
SAEYY - RXMD
4%
Poorly correlated
-2.95%
More

WLCGF and

Correlation & Price change

A.I.dvisor tells us that WLCGF and SGIPF have been poorly correlated (+1% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WLCGF and SGIPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WLCGF
1D Price
Change %
WLCGF100%
N/A
SGIPF - WLCGF
1%
Poorly correlated
N/A
NVACF - WLCGF
0%
Poorly correlated
N/A
RADLY - WLCGF
0%
Poorly correlated
+7.42%
SAEYY - WLCGF
0%
Poorly correlated
-2.95%
RXMD - WLCGF
-0%
Poorly correlated
N/A
More